Definiens has tapped Ralf Huss to serve as its chief medical officer. In this position, Huss will play a key role in expanding the company's reach in the image and data analysis market, the company said.
Huss is a surgical and anatomical pathologist with more than 20 years of training and experience in histopathology and cancer research. Prior to joining Definiens, he served as the global head of the histopathology and tissue biomarker arm at Roche Diagnostics. He also co-founded Apceth, a German biotech company, and he holds academic appointments at the Ludwig-Maximilians-University in Munich and the Wake Forest Institute for Regenerative Medicine.